Sundrug CoTSE:9989 +0.11%81 Net Margin % is 4.12% as of Dec. 2025, which is 7% above its 10-year median of 3.86. GuruFocus rates TSE:9989 with a GF Score™ of 81/100 and a GF Value™ of 円4,717.16 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 668 Healthcare Providers & Services companies, Sundrug Co ranks better than 55.39% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Sundrug Co's Net Income for the
three
months ended in Dec. 2025 was 円8,962 Mil. Sundrug Co's Revenue for the
three
months ended in Dec. 2025 was 円217,270 Mil. Therefore, Sundrug Co's net margin for the quarter that ended in Dec. 2025 was 4.12%.
The historical rank and industry rank for Sundrug Co's Net Margin % or its related term are showing as below:
TSE:9989'
s Net Margin % Range Over the Past 10 Years
Min: 3.68 Med: 3.86 Max: 4.41
Current: 3.73
TSE:9989's Net Margin % is ranked better than 55.39% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs TSE:9989: 3.73
Sundrug Co (TSE:9989) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Sundrug Co Net Margin % Related Terms
Sundrug Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Sundrug Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Sundrug Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sundrug Co Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sundrug Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Sundrug Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sundrug Co (TSE:9989) has a Net Margin % of 4.12% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Sundrug Co and its competitors. This is near median its historical median of 3.86. Over the past decade, Sundrug Co's Net Margin % has ranged from 3.68 to 4.41. According to the industry distribution chart, Sundrug Co ranks #298 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 44.6%.
Is Sundrug Co's Net Margin % too high?
Sundrug Co's current Net Margin % of 4.12% is near median its 10-year median of 3.86. Over the past 10 years, this metric has ranged from a low of 3.68 to a high of 4.41. The Healthcare Providers & Services industry median Net Margin % is 2.89. Sundrug Co's value of 4.12% is 42.8% above this industry median. Based on the distribution chart, Sundrug Co ranks #298 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sundrug Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sundrug Co's Net Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sundrug Co ranks #298 out of 668 companies for Net Margin %. This puts Sundrug Co in the upper half of its industry. The industry median Net Margin % is 2.89. Sundrug Co's value of 4.12% is 42.8% above this benchmark. Historically, Sundrug Co's own Net Margin % has ranged from 3.68 to 4.41 over the past decade. While the company's 10-year median is 3.86 vs. the industry median of 2.89, Sundrug Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sundrug Co's current Net Margin % of 4.12% is 42.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Sundrug Co and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sundrug Co's current Net Margin % is 4.12%, which is near median its own 10-year median of 3.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sundrug Co stock overvalued right now?
Based on GuruFocus' analysis, Sundrug Co (TSE:9989) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,717.16, compared to a current price of 円3,768.00 — trading 20.1% below its estimated fair value. The current Net Margin % is 4.12%, which is near median its 10-year median of 3.86 and 42.8% above the Healthcare Providers & Services industry median of 2.89. Sundrug Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Sundrug Co (TSE:9989), the current Net Margin % is 4.12% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sundrug Co (TSE:9989) Overvalued in 2026?
Based on GuruFocus' analysis, Sundrug Co stock appears to be undervalued.
The current stock price of 円3,768.00 is trading 20.1% below its estimated GF Value™ of 円4,717.16.
GuruFocus considers Sundrug Co to be Modestly Undervalued.
Key valuation signals for TSE:9989:
Net Margin %: 4.12% (near median its 10-year median of 3.86)
GF Value™: 円4,717.16 vs. price of 円3,768.00 (20.1% below fair value)
Industry Position: 42.8% above the Healthcare Providers & Services median (#298 of 668)
No single metric tells the full story. See the TSE:9989 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sundrug Co Ltd is a Japanese-based company engaged in the operation of drug stores and discount stores. The Group operates through two segments: the Drug Store Business, which mainly sells pharmaceuticals, cosmetics, and daily necessities, and the Discount Store Business, which mainly sells food products, household goods, and other related items. It generates the majority of its revenue from the Drugstore business segment.
81GF Score
Get the complete analysis for TSE:9989
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9989 has been successfully added to your 
